Pre Seed · Healthtech · London, United Kingdom · Founded 2025 · 1–10 employees
Juno develops an AI-powered personal health assistant designed specifically for individuals living with chronic and invisible illnesses, including ME/CFS, POTS, fibromyalgia, and Long COVID. The platform allows users to track symptoms, mood, and energy levels using natural voice or text conversations rather than structured manual forms. Integrated with wearable devices, the system identifies long-term physiological patterns and generates doctor-ready summary reports to streamline medical appointments. The company participated in the Y Combinator Spring 2026 batch and secured a $250,000 SAFE investment from Robinhood Ventures Fund II.
No open roles listed right now.